Unexplained Drowsiness in a Case of Stroke

Speciality: Family Physicians


Speaker:

Dr. Rajesh Gadia | DNB (Med)

Description:

 A warm welcome to all the medical professionals in this interesting session on Unexplained Drowsiness in a Case of Stroke
Clinical Presentation and Concerns:
Unexplained drowsiness in a patient with a stroke is a significant clinical concern that necessitates immediate investigation. Drowsiness or altered mental status in the context of a stroke can indicate the severity and extent of brain injury. It may result from direct damage to brain regions responsible for consciousness, such as the reticular activating system, or secondary effects like increased intracranial pressure, edema, or hemorrhagic transformation of an ischemic stroke.
Potential Causes:
Several factors can contribute to drowsiness in stroke patients. These include cerebral hypoperfusion, metabolic imbalances, or infections like pneumonia or urinary tract infections, which are common post-stroke complications. Medication side effects, particularly from sedatives or anticonvulsants used to manage post-stroke seizures, can also cause drowsiness. Additionally, comorbid conditions such as dehydration, electrolyte imbalances, or renal dysfunction should be considered.
Diagnostic Approach:
Evaluating unexplained drowsiness in a stroke patient involves a comprehensive assessment, including a thorough clinical history, neurological examination, and appropriate diagnostic tests. Imaging studies such as CT or MRI scans are crucial to identify potential complications like hemorrhage or new ischemic events. Blood tests, including complete blood count, electrolytes, renal

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

Why Encouragement May Not Improve Motivation in Depression

3.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

4.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

5.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot